Drug intelligence / Profile preview

Wenweishu Tablets

Development stage: Unknown
Lead developer: Chengdu Yongkon Pharmacy
Administration: Oral

Overview

Wenweishu Tablets (温胃舒片) is an approved traditional Chinese medicine (TCM) formulated as a tablet and developed by Chengdu Yongkon Pharmacy. It is composed of a mixture of twelve herbal ingredients, including Radix Astragali (Huangqi), Radix Codonopsis (Dangshen), Radix Aconiti Lateralis Praeparata (Fuzi), Rhizoma Dioscoreae (Shanyao), Rhizoma Atractylodis Macrocephalae (Baizhu), Cortex Cinnamomi (Rougui), Fructus Crataegi (Shanzha), Pericarpium Citri Reticulatae (Chenpi), Fructus Amomi (Sharen), Herba Cistanches (Roucongrong), Fructus Mume (Wumei), and Fructus Psoraleae (Buguzhi). Wenweishu Tablets are indicated for warming the stomach, promoting Qi circulation, and relieving pain, and are clinically used to treat chronic gastritis, chronic atrophic gastritis, and stomach pain (epigastric cold pain) caused by deficiency-cold of the spleen and stomach.

Brand names: Wenweishu Tablets
Other names: Wenweishu温胃舒片

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)BAX (Apoptosis regulator BAX)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CASP3 (Caspase-3)IL-6 (Interleukin 6)NFKBIA (NFKB inhibitor alpha)RELA (Nuclear Factor Kappa B Subunit p65)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PTEN (Phosphatase and tensin homolog deleted on chromosome ten)TNFA (Tumor necrosis factor alpha (soluble))TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Wenweishu Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wenweishu Tablets.